Spatial Transcriptomics in Breast Cancer Reveals Tumour Microenvironment-Driven Drug Responses and Clonal Therapeutic Heterogeneity
M. J. Jimenez-Santos, S. Garcia-Martin, M. Rubio-Fernandez, G. Gomez-Lopez, F. Al-Shahrour
This study uses spatial transcriptomics to analyze drug responses in breast cancer tumors and identifies therapeutic heterogeneity linked to tumor location and microenvironment.
bioRxiv · Feb 18, 2024 · PreprintCancer Biology